Phd MD Dilip Mehta Net Worth & Insider Trades

Phd MD Dilip Mehta - Director, Spectrum Pharmaceuticals Inc

As of July 6, 2010

What is Phd MD Dilip Mehta's Net Worth?

The current estimated net worth of Spectrum Pharmaceuticals Inc's Director, Phd MD Dilip Mehta, is estimated to be about $27.52K . Phd MD Dilip Mehta owns about 32,000 units of Spectrum Pharmaceuticals Inc common stock. In the last 6 years at Spectrum Pharmaceuticals Inc, Phd MD Dilip Mehta has sold an estimated value of $0 worth.

What is Phd MD Dilip Mehta's Past Insider Trading?

Phd MD Dilip Mehta's largest purchase order was 10,000 units , worth over $37.37K on July 6, 2010. In total, Phd MD Dilip Mehta has made about 7 transactions over 6 years of their time at Spectrum Pharmaceuticals Inc. Phd MD Dilip Mehta usually trades in July, with the busiest year in 2005, 2004 and 2010.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dilip J. Mehta

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Phd MD Dilip Mehta's' Mailing Address?

  • Mailing address is 870 United Nation Plaza Apt 16e New York NY 10017 NY

What are Spectrum Pharmaceuticals Inc's Past Insider Trades?

Spectrum Pharmaceuticals Inc's most recent insider trade came on May 30, 2023 by Nora Brennan who sold 32,387 units worth $35.5K . In the last 19 years, insiders at Spectrum Pharmaceuticals Inc have sold an estimated value of $110.07M and bought an estimated value of $61.8M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Rajesh C. Shrotriya, Director,  Anthony E. Maida, Director,  and Joseph W Turgeon, CEO & President .

SPECTRUM PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...